白质高信号调节糖尿病与非阿尔茨海默脑萎缩的关联
本研究基于两个记忆门诊队列(Harmonization 和 ADNI),纳入无痴呆个体,纵向评估脑MRI和认知,发现糖尿病本身不与脑萎缩相关,但与白质高信号存在交互作用,协同导致非AD特异性脑萎缩,且皮质灰质介导了高白质高信号负荷下糖尿病对认知的影响。
要点
- 糖尿病与白质高信号协同促进非AD脑萎缩,独立于AD病理。
- 糖尿病相关认知障碍可能主要由脑血管病驱动,而非阿尔茨海默病理。
- 皮质灰质萎缩介导高白质高信号负荷下糖尿病对认知的影响。
核心结论
- 糖尿病与白质高信号协同导致脑萎缩,独立于阿尔茨海默病,提示糖尿病相关认知障碍主要由脑血管病驱动。
研究设计与样本
- 研究纳入两个独立记忆门诊队列的无痴呆个体:Harmonization队列(主要分析,糖尿病112例,对照284例)和ADNI队列(次要分析,糖尿病64例,对照600例),进行纵向脑MRI和认知评估,并测量血浆pTau181。
主要发现
- 糖尿病与脑萎缩在横断面和纵向上均无显著关联。
- 在Harmonization队列中,糖尿病与白质高信号对皮质灰质和额叶萎缩存在显著交互作用,该交互作用在调整血浆pTau181后仍显著。
- 在ADNI队列中,糖尿病与白质高信号交互加速随时间变化的脑萎缩。
- 在高白质高信号负荷下,皮质灰质介导了糖尿病对认知的影响。
临床怎么用
- 对于糖尿病患者,应评估白质高信号负荷以识别脑萎缩和认知障碍高风险个体。
- 糖尿病相关认知障碍的防治应重视脑血管病管理而非仅针对阿尔茨海默病理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: White matter hyperintensities (WMHs) moderate the association between diabetes and cognition, but the underlying mechanisms remain unknown. This study investigated the interaction effect between diabetes and WMHs on brain atrophy, the resulting atrophy patterns, and whether brain atrophy mediates the effect of diabetes on cognition. RESEARCH DESIGN AND METHODS: This study included individuals without dementia from two independent memory clinic-based cohorts: Harmonization (primary analysis, n = 112 case subjects with diabetes, n = 284 control subjects) and Alzheimer's Disease Neuroimaging Initiative (ADNI) (secondary analysis, n = 64 case subjects with diabetes, n = 600 control subjects). Participants underwent longitudinal brain MRI and cognitive assessments, along with plasma pTau181 measurement as a marker of Alzheimer disease (AD). WMHs and brain atrophy were quantified, with Schwarz signature, McEvoy signature, and hippocampal volume used as AD-specific atrophy measures. RESULTS: Diabetes was not associated with brain atrophy cross-sectionally or longitudinally. Instead, an interactive effect between diabetes and WMHs on brain atrophy was observed. In Harmonization, this interaction was significant in cross-sectional analyses, affecting cortical gray matter and the frontal lobe. No interactive effect was found for AD-specific atrophy, and the observed interactive effect remained significant after adjusting for plasma pTau181. Cortical gray matter mediated the effect of diabetes on cognition at higher WMHs burden. These results were replicated in ADNI, where diabetes and WMHs interacted to accelerate brain atrophy over time. CONCLUSIONS: Our study demonstrated diabetes and WMHs synergistically contribute to brain atrophy independent of AD, suggesting diabetes-associated cognitive impairment is primarily driven by cerebrovascular disease rather than Alzheimer pathology.
引用
- Cui J, Liu Z, Tan WY, et al. White Matter Hyperintensities Moderate the Association Between Diabetes and Non-AD Brain Atrophy. Diabetes Care. 2026. PMID: 41144252. doi:10.2337/dc25-1162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。